By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.


Westport, CT (September 12, 2016) – CTFN, the financial industry’s leading M&A news service, will provide real-time coverage of several milestone federal trials scheduled for this fall, including the historic healthcare antitrust trials.

Case coverage will include: the Humana/Aetna and Cigna/Anthem antitrust cases, the MetLife appeal in the Too-Big- to-Fail SOFI case, the ongoing litigation between Alere and Abbott, the FannieMae/Freddie Mac litigation, and the appeal of the Sanofi/Regeneron cholesterol patent.

CTFN is the only news organization covering these significant cases on a live basis, from end to end. The upcoming coverage will enable subscribers access to critical information stemming from the proceedings.

Over the past 16 months, CTFN covered every major antitrust trial with unprecedented in-courtroom start-to- finish reporting every day of the proceedings, including:

  • Office Depot/Staples
  • Synergy/Steris
  • GE/Electrolux
  • US Foods/Sysco

In addition, CTFN will continue to provide near real-time coverage of the Alere/Abbott and Williams/Energy Transfer cases in Delaware Chancery Court, allowing CTFN’s clients to make key investment decisions on these and other important legal proceedings.

CTFN’s reporting has been credited for impacting markets and has been quoted in Bloomberg, Seeking Alpha, Business Insider, the Financial Times, Forbes and national consumer outlets such as Vanity Fair.

To learn more about CTFN visit:


Press Contact

Mary Helen Sullivan



About CTFN

Designed to serve event-driven investors and deal professionals, CTFN delivers a fresh perspective on mergers, major corporate actions and event-driven investment topics, including special situations, litigation, and legislation. The publication’s mission is to provide the best researched news to aid subscribers in making critical business decisions. Reporting from several North American and European cities, CTFN has a team of seasoned reporters who publish daily news that subscribers depend on in order to dissect the market issues most pertinent to them. For subscription inquiries email Learn more at

Press Contact

Mary Helen Sullivan


# # #


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.